Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Acutus Medical, Inc. (AFIB) had Revenue of $20.16M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$20.16M
Net Income	$-9.55M
Cost of Goods Sold	$19.14M
Gross Profit	$1.01M
Operating Expenses	$20.21M
Operating Income	$-0.06M
Non-Operating Income/Expense	$-4.48M
Pre-Tax Income	$-4.54M
Normalized Pre-Tax Income	$-4.54M
Income after Taxes	$-4.54M
Income from Continuous Operations	$-4.54M
Consolidated Net Income/Loss	$-9.55M
Normalized Income after Taxes	$-4.54M
EBIT	$-0.06M
EBITDA	$1.87M
Weighted-Average Shares Outstanding (Basic)	29.77M
Weighted-Average Shares Outstanding (Diluted)	29.77M
Earnings per Share (EPS) (Basic)	$-0.32
Earnings per Share (EPS) (Diluted)	$-0.32
Balance Sheet Financials
Current Assets	$25.58M
Property, Plant, and Equipment	$0.52M
Long-Term Assets	$3.07M
Total Assets	$28.65M
Current Liabilities	$12.44M
Long-Term Debt	$25.56M
Long-Term Liabilities	$27.80M
Total Liabilities	$40.24M
Common Equity	$-11.59M
Tangible Shareholders Equity	$-11.59M
Shareholders Equity	$-11.59M
Common Shares Outstanding	29.91M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-31.66M
Cash Flow from Investing Activities	$22.15M
Cash Flow from Financial Activities	$-2.89M
Beginning Cash	$26.20M
End Cash	$14.02M
Increase/Decrease in Cash	$-12.18M
Stock-Based Compensation	$0.46M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.06
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	1.83
Debt to Equity Ratio	-2.81
Gross Margin	5.03%
Operating Margin	-0.28%
EBIT Margin	-0.28%
EBITDA Margin	9.29%
Pre-Tax Profit Margin	-22.50%
Profit Margin	-47.36%
Free Cash Flow	$-31.77M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.70
Inventory Turnover	10.70
Receiveable Turnover	2.56
Days Sales in Receivables	142.65
Return on Equity	39.13%
Return on Tangible Equity	39.13%
Return on Assets	-15.83%
Return on Investments	-32.46%
Book Value Per Share	$-0.39
Free Cash Flow per Share	$-1.07
Operating Cash Flow per Share	$-1.06

Data from Zacks Investment Research, Inc.